By Robert Izquierdo
Publication Date: 2025-11-19 20:32:00
The investment firm showed confidence in Teladoc’s growth potential by increasing its holdings in the stock.
What happened
According to a Filing with the Securities and Exchange Commission (SEC). As of November 18, 2025, Oracle Investment Management, which specializes in investing in the healthcare and life sciences industries, purchased 324,416 additional shares of Teladoc Health (TDOC +0.71%). The latest holdings totaled 705,416 shares valued at $5.45 million as of September 30, 2025. This represents a net increase in position value of $2.13 million since the previous quarter, reflecting both stock purchases and share price changes.
What else you should know
This purchase brings Teladoc Health to 3.4% of ORACLE Investment Management’s 13F assets under management, making it the fund’s fourth-largest holding.
Top Holdings Post-Submission:
- NASDAQ: WGS: $95.88 million (60.0% of AUM)
- NYSE: BHVN: $11.11 million (6.9% of AUM)
- NASDAQ: ARDX: $8.29 million (5.2% of AUM)
- NYSE: TDOC: $5.45 million (3.4% of AUM)
- NASDAQ:PLTR: $5.38…
